In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.

Many anti-cancer drugs fail in human trials despite showing efficacy in preclinical models. It is clear that the in vitro assays involving 2D monoculture do not reflect the complex extracellular matrix, chemical, and cellular microenvironment of the tumor tissue, and this may explain the failure of...

Full description

Bibliographic Details
Main Authors: Gabriel Benton, Gerald DeGray, Hynda K Kleinman, Jay George, Irina Arnaoutova
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4391795?pdf=render
_version_ 1819048230477889536
author Gabriel Benton
Gerald DeGray
Hynda K Kleinman
Jay George
Irina Arnaoutova
author_facet Gabriel Benton
Gerald DeGray
Hynda K Kleinman
Jay George
Irina Arnaoutova
author_sort Gabriel Benton
collection DOAJ
description Many anti-cancer drugs fail in human trials despite showing efficacy in preclinical models. It is clear that the in vitro assays involving 2D monoculture do not reflect the complex extracellular matrix, chemical, and cellular microenvironment of the tumor tissue, and this may explain the failure of 2D models to predict clinical efficacy. We first optimized an in vitro microtumor model using a tumor-aligned ECM, a tumor-aligned medium, MCF-7 and MDA-MB-231 breast cancer spheroids, human umbilical vein endothelial cells, and human stromal cells to recapitulate the tissue architecture, chemical environment, and cellular organization of a growing and invading tumor. We assayed the microtumor for cell proliferation and invasion in a tumor-aligned extracellular matrix, exhibiting collagen deposition, acidity, glucose deprivation, and hypoxia. We found maximal proliferation and invasion when the multicellular spheroids were cultured in a tumor-aligned medium, having low pH and low glucose, with 10% fetal bovine serum under hypoxic conditions. In a 7-day assay, varying doses of fluorouracil or paclitaxel had differential effects on proliferation for MCF-7 and MDA-MB-231 tumor spheroids in microtumor compared to 2D and 3D monoculture. The microtumors exhibited a tumor morphology and drug response similar to published xenograft data, thus demonstrating a more physiologically predictive in vitro model.
first_indexed 2024-12-21T11:12:57Z
format Article
id doaj.art-55f7a83ab69040f4972fa455d8dc9b8a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T11:12:57Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-55f7a83ab69040f4972fa455d8dc9b8a2022-12-21T19:06:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012331210.1371/journal.pone.0123312In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.Gabriel BentonGerald DeGrayHynda K KleinmanJay GeorgeIrina ArnaoutovaMany anti-cancer drugs fail in human trials despite showing efficacy in preclinical models. It is clear that the in vitro assays involving 2D monoculture do not reflect the complex extracellular matrix, chemical, and cellular microenvironment of the tumor tissue, and this may explain the failure of 2D models to predict clinical efficacy. We first optimized an in vitro microtumor model using a tumor-aligned ECM, a tumor-aligned medium, MCF-7 and MDA-MB-231 breast cancer spheroids, human umbilical vein endothelial cells, and human stromal cells to recapitulate the tissue architecture, chemical environment, and cellular organization of a growing and invading tumor. We assayed the microtumor for cell proliferation and invasion in a tumor-aligned extracellular matrix, exhibiting collagen deposition, acidity, glucose deprivation, and hypoxia. We found maximal proliferation and invasion when the multicellular spheroids were cultured in a tumor-aligned medium, having low pH and low glucose, with 10% fetal bovine serum under hypoxic conditions. In a 7-day assay, varying doses of fluorouracil or paclitaxel had differential effects on proliferation for MCF-7 and MDA-MB-231 tumor spheroids in microtumor compared to 2D and 3D monoculture. The microtumors exhibited a tumor morphology and drug response similar to published xenograft data, thus demonstrating a more physiologically predictive in vitro model.http://europepmc.org/articles/PMC4391795?pdf=render
spellingShingle Gabriel Benton
Gerald DeGray
Hynda K Kleinman
Jay George
Irina Arnaoutova
In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
PLoS ONE
title In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
title_full In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
title_fullStr In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
title_full_unstemmed In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
title_short In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening.
title_sort in vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screening
url http://europepmc.org/articles/PMC4391795?pdf=render
work_keys_str_mv AT gabrielbenton invitromicrotumorsprovideaphysiologicallypredictivetoolforbreastcancertherapeuticscreening
AT geralddegray invitromicrotumorsprovideaphysiologicallypredictivetoolforbreastcancertherapeuticscreening
AT hyndakkleinman invitromicrotumorsprovideaphysiologicallypredictivetoolforbreastcancertherapeuticscreening
AT jaygeorge invitromicrotumorsprovideaphysiologicallypredictivetoolforbreastcancertherapeuticscreening
AT irinaarnaoutova invitromicrotumorsprovideaphysiologicallypredictivetoolforbreastcancertherapeuticscreening